Efficacy of omalizumab in food allergic adults - A retrospective analysis
Our real-world evidence data indicate efficacy and tolerability of OMA for the treatment of IgE-mediated food allergy with and without OIT. As the onset of food related reactions upon treatment was frequently linked to the presence of cofactors, these should be identified and considered in patients with food allergy-not only for diagnosis, but also in treatment settings.
Authors
- Aikaterina Alexiou (ORCID: https://orcid.org/0000-0001-8674-5529)
- Regina Treudler (ORCID: https://orcid.org/0000-0002-9642-4742)
- Victòria Cardona (ORCID: https://orcid.org/0000-0003-2197-9767)
- Margitta Worm (ORCID: https://orcid.org/0000-0002-3449-1245)
- Sofia Carreras Kàtcheff (ORCID: https://orcid.org/0009-0001-1223-1557)
- Karin Hartmann (ORCID: https://orcid.org/0000-0002-4595-8226)
- Paolo Tassinari (ORCID: https://orcid.org/0000-0003-0205-1795)
Institutions
- Novartis (Switzerland) (CH)
- University of Basel (CH)
- University Hospital of Basel (CH)
- ENT and Allergy (US)
- Clinical Research Center for Hair and Skin Science (DE)
- Vall d'Hebron Hospital Universitari (ES)
- Charité - Universitätsmedizin Berlin (DE)
- Leipzig University (DE)
Publication Details
- Journal
- World Allergy Organization Journal
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.waojou.2025.101048
- Citations
- 6
- Primary Topic
- Food Allergy and Anaphylaxis Research
- Type
- article
- Field-Weighted Citation Impact
- 9.73
Funders
- Deutsche Forschungsgemeinschaft